{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-084689","form_type":"8-K","ticker":"OCGN","cik":"0001372299","company_name":"Ocugen, Inc.","filed_at":"2024-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.816293+00:00","generated_at":"2026-05-31T13:43:15.277893+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Ocugen prices $35M public offering of 30.4M shares at $1.15 per share","bullets":["Gross proceeds of $35M; net proceeds expected ~$32.6M after underwriting discounts.","Underwriter granted 30-day option to purchase up to 4,565,217 additional shares at same price.","Proceeds to be used for general corporate purposes, working capital, and G&A expenses.","Offering expected to close on or about August 2, 2024; Titan Partners Group sole book-runner.","Financing led by a premier mutual fund with participation from leading life sciences investors."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-084689","json":"https://secwatch.observer/filing/0001104659-24-084689.json","markdown":"https://secwatch.observer/filing/0001104659-24-084689.md","text":"https://secwatch.observer/filing/0001104659-24-084689.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372299/000110465924084689/0001104659-24-084689-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372299/000110465924084689/tm2420013d3_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:43:15.277893+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}